Patent · US Active

Forms and compositions of a MK2 inhibitor

US11629153B2 · kind B2 · utility

1Cited by

11References

33Claims

0Family size

Assignee

Celgene CAR LLC · BM

Inventors

Jianxin Han · Green Brook, US
Lianfeng Huang · Jalan Pedongkelan, US
Uday Jain · Rahway, US
Ying Li · Millburn, US
John Malona · Brookline, US
Kevin Molter · Summit, US
Chittari Pabba · Slingerlands, US
Alexander L. Ruchelman · Cream Ridge, US
Jean Xu · Hackettstown, US
Daozhong Zou · Bound Brook, US

Key dates

Filing date	Dec 29, 2020
Grant date	Apr 18, 2023
Priority date	—
Expiry date	May 14, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/005
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides solid forms of an MK2 inhibitor, compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.